Pharma industry staying afloat amidst supply chain disruptions roar

     

The pharma industry with its primary supplier base in China and India has been rocked by several supply disruptions over the years, and more recently by the pandemic. This paper traces the effect of these disruptions on the industry and lists some areas for companies to work on, towards developing greater supply resilience.

Click here to Download

Register to download